Roche revolutionizes pharmaceutical research with Azure Confidential Computing
Roche has implemented Azure Confidential Computing to securely analyze sensitive patient data in pharmaceutical research and drug development. By leveraging state-of-the-art security features including clean rooms and Intel SGX-powered Azure DCsv3 VMs, Roche ensures compliance and enhances trust in technology while fostering collaboration with hospitals for clinical studies. This solution creates a secure environment for sharing critical patient data without compromising its confidentiality, embodying Roche's ambition to develop advanced technology-driven, privacy-respecting healthcare innovations.
- Organization
- Roche
- Industry
- Healthcare
- Location
- Switzerland
- Published
- September 2022
Reported outcomes
Strategic outcomes
Why do we believe this deployment?Customer identity, provider attribution, maturity, and source checks
- Customer
- Roche
- Provider
- Microsoft
- Maturity
- Unknown
- Linked source
- Microsoft News
No explicit deployment-stage evidence found.
Primary read
Use case focus
Showing 3 of 3
- 1confidential computing for clinical trials
- 2patient data protection
- 3pharmaceutical research
- Securely managing sensitive patient data during clinical research.
- Ensuring compliance with stringent patient data protection standards.
- Maintaining institutional and public trust in data privacy.
- Facilitating inter-organizational collaboration without risking data exposure.
- Deployment of Azure Confidential Computing with Intel SGX-powered Azure DCsv3 VMs.
- Creation of secure environments for data lifecycle protection.
- Integration of privacy-respecting analytics during drug development.
- Shared data systems with hospitals for research and clinical insights.
- Seamless compliance with national and international data regulations.
- Fostered trust between stakeholders and patients.
- Improved efficiency in analyzing sensitive medical data.
- Enhanced collaboration among research institutions and hospitals.
Architecture
The system utilizes Intel SGX-powered Azure DCsv3 VMs to create a confidential computing environment for patient data analysis throughout its lifecycle, ensuring encrypted and secure processing.
Sources & evidence1
- Customer explicitly identified
- Independent source available
- Technical implementation details available
- Recent evidence check available
- Last evidence check: Jul 22, 2026.
The same organization appears in newer AI deployment evidence.
- Same organization re-documented as recently as 2025.
- Cited source last checked Jun 12, 2026 — ok (0/1 broken).
Measures whether this deployment's public evidence persists — not whether the system is still in production.
AI-generated summary. Verify important details with the linked sources before relying on this case.
Explore related AI use cases
Was this useful?
Community
Comments
No published comments yet.